Navigation Links
DURATION-6 Top-Line Study Results Announced
Date:3/3/2011

week) (n=461) or Victoza (forced titration to 1.8 mg, once per day) (n=451). The primary endpoint was reduction in A1C, while secondary endpoints included change in body weight along with other parameters of glucose control, cardiovascular health and safety and tolerability.

About Diabetes

Diabetes affects nearly 26 million people in the U.S. and an estimated 285 million adults worldwide.(i, ii)  Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes costs approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data indicate that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi, vii)

About BYETTA® (exenatide) injection

BYETTA was the first GLP-1 receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program. BYETTA is not insulin and should not be taken instead of insulin. BYETTA is not currently recommended to be taken with insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis. BYETTA has not been studied in people who have pancreatitis.

BYETTA provides sustained A1C control and low incidence
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen Announces Top-Line Phase II Results on Velafermin
2. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Schering-Plough Reports Top-Line Results of the IDEAL Study
5. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
6. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
7. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
8. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
9. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
10. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
11. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... The western European automated endoscope reprocessor ... a replacement market with fewer new installations due ... partnerships are redefining competitive landscape in western ... details about revenue forecasts, unit shipments, market share ... country. The changing landscape makes it important to ...
(Date:9/22/2014)... -- Research and Markets  has announced the addition ... report to their offering. This newly ... up-to-date publication available covering the neurotechnology industry. The report ... and growth rates in four key segments of the ... forecasts the number of systems to be sold, worldwide ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3
... , Increased vaccination ... gaps remain, others must join effort , DAVOS, Switzerland ... announced today that their foundation will commit $10 billion ... deliver vaccines for the world,s poorest countries. , (Photo: ...
... , , REDWOOD CITY, Calif. ... today announced financial results for its fiscal second quarter and six months ... call at 4:30 p.m. Eastern Time to discuss the financial ... quarter, as we continued to transition the sales model for our cardiac ...
Cached Medicine Technology:Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 2Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 3Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 4Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 5Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 2Cardica Announces Fiscal 2010 Second Quarter Financial Results 3Cardica Announces Fiscal 2010 Second Quarter Financial Results 4Cardica Announces Fiscal 2010 Second Quarter Financial Results 5Cardica Announces Fiscal 2010 Second Quarter Financial Results 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 7Cardica Announces Fiscal 2010 Second Quarter Financial Results 8Cardica Announces Fiscal 2010 Second Quarter Financial Results 9
(Date:9/23/2014)... Sandpoint, Idaho (PRWEB) September 23, 2014 ... GunSafes.com is now offering SecureIt Tactical products ... prices. SecureIt Tactical, Inc. holds a good name in ... The company stores only the finest products and now ... tactical gun safes such as the MilSpec Tactical Safe ...
(Date:9/22/2014)... Vida Cannabis Corp . is ... Agreement with Florida-based AltMed LLC . , ... and technical expertise. They’ll also pool business development ... markets. , "We’re deeply impressed with the level ... Cannabis team as they work toward building the most ...
(Date:9/22/2014)... Detroit MI (PRWEB) September 23, 2014 ... 3 organization dedicated to serving patients, caregivers and families ... of Philip M. Fortier of Detroit, MI to its ... disease of the brain and spinal cord, and is ... addition to resembling Parkinson’s disease (MSA Type P), MSA ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Airbus Helicopters ... industry Monday for their efforts to improve safety and ... Award and the Program of the Year award, both ... Air Medical Transport Conference Annual Community Awards. , ... with the Jim Charlson Aviation Safety Award, given annually ...
(Date:9/22/2014)... United States District Judge Joseph ... mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) filed against defendant ... pretrial matters, issued an order in the multidistrict ... Products Liability Litigation (United States District Court for ... 2:12-md-02326)—requiring that four member cases be ready for ...
Breaking Medicine News(10 mins):Health News:GunSafes.com Now Offers Secure Tactical Range of Gun Safes 2Health News:Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2
... U.S. Environmental,Protection Agency has given $97,204 to ... providers and women of child-bearing age on,environmental health ... grants nationwide. In Ohio, the grant will be ... woman,s potential exposure to environmental,risks., The EPA ...
... N.J., Feb. 4 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP ... and chief operating officer, is scheduled to present at ... York on Monday, February,11, 2008 at 1:15 p.m. ET. ... a replay available approximately three hours after the,presentation has ...
... MONDAY, Feb. 4 (HealthDay News) -- Drug-coated stents are better ... research finds. , "There are two messages I would take ... professor of cardiology at Wake Forest University and lead author ... Journal of the American College of Cardiology. "The ...
... has,agreed to settle for $2.5 million, plus interest, ... program, the Justice Department,announced today. The settlement is ... Medical Center is currently in bankruptcy., The ... to Medicare patients in order to obtain enhanced,reimbursement ...
... ALTO, Calif., Feb. 4 Formerly conjoined twins,Yurelia ... at Stanford and are now home in Costa ... Children,s last Wednesday (30) and went,to Southern California ... sponsor the girls, trip. Today (4), they flew ...
... Those with poor balance, dementia, vision loss most in peril, ... -- Certain people are at high risk for accidental falls ... number of fall-related injuries and deaths in the United States, ... States, accidental falls result in 1.8 million emergency room visits ...
Cached Medicine News:Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 2Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 3Health News:Buyer of Bayonne Hospital to Pay U.S. $2.5 Million to Resolve Allegations of Medicare Fraud 2Health News:Formerly Conjoined Twins Leave Packard Children's Hospital; Heading Home to Costa Rica 2Health News:New Guideline Urges Screening for Fall Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: